Ahead Therapeutics – In the News
Martí Dalmases, CEO of Ahead therapeutics, will attend to BIO Investor Forum 2019 this month on behalf of the company....Read More
Ahead Therapeutics has reached an agreement with Prof. Dr. med.-univ. Schett from University Erlangen-Nürnberg to advance in the preclinical development of AT_1001.
The agreement will allow Ahead Therapeutics to validate the platform potential of the PS-Liposomes using the Rheumatoid Arthritis in vivo...Read More
Ahead Therapeutics attended ICONAN 2019 International Conference on Nanomedicine and Nanobiotechnology – ICONAN 16th-18th October
Ahead Therapeutics participated in the ICONAN conference 2019 (https://www.controlledreleasesociety.org/events/2019-international-conference-nanomedicine-and-nanobiotechnology-iconan). Nanomedicine and Nanobiotechnology have tremendous potential for tomorrow’s patient care in...Read More